Labour has unveiled a £340 million expansion of England’s Pharmacy First scheme; in a move ministers say will ease pressure on overstretched GP surgeries by allowing pharmacists to treat a wider range of common conditions from later this year.
The funding package will extend the service to cover five additional conditions from autumn, although the Government has yet to confirm which ailments will be included. The scheme already enables community pharmacists to assess patients and provide treatment for a range of minor illnesses, including sore throats, ear infections, sinusitis, shingles, impetigo, infected insect bites and urinary tract infections.
First launched in 2024, Pharmacy First was designed to redirect patients with low-level conditions away from GP practices and hospital emergency departments, allowing them to access advice, over-the-counter remedies and prescription-only medicines directly from local pharmacies.
Between March 2025 and February 2026, more than 3.3 million consultations were delivered through the programme, according to the Department of Health and Social Care, underscoring its rapid uptake across England.
Health minister Stephen Kinnock said the expansion would make greater use of pharmacists’ clinical training and help reshape access to frontline care.
“Independent prescribing will play a major part in delivering this shift, easing pressures on GPs, cutting unnecessary red tape and helping patients get the right care closer to home,” he said.
The Government said the changes were part of a broader effort to modernise primary care, with ministers arguing that pharmacies can play a larger role in managing routine conditions and reducing demand on the wider NHS system.
However, the announcement has been met with caution from sector leaders, who warn that the financial package does not address long-standing pressures on community pharmacies.
The National Pharmacy Association said that while the expansion direction was welcome, it would do little to resolve what it described as a “crippling” funding shortfall.
Chairman Dr Olivier Picard said the plan “points in the right direction” but warned it failed to close a £2.5 billion funding gap previously identified within the NHS system.
He added that the reforms were “nowhere near ambitious enough to transform patient access to care, nor make full use of pharmacists’ skills”, arguing that rising operating costs continue to threaten the viability of many community pharmacies.
Similar concerns were raised by the Independent Pharmacies Association, which represents around 5,000 pharmacies across England and Wales. Chief executive Dr Leyla Hannbeck said the proposals were “a step in the right direction” but warned that funding levels would not cover the additional workload being placed on the sector.
She cautioned that some pharmacists were already struggling to remain financially sustainable, adding that many were being forced to question whether they could continue operating under current conditions.
The National Pharmacy Association also warned that escalating business rates, staffing costs and pressure on medicine prices were continuing to erode margins, with some pharmacies describing additional workload commitments as potentially “loss-making”.
Ministers insist the reforms will improve access to care and reduce pressure elsewhere in the NHS, but the dispute highlights growing tension between the Government’s ambition to expand community healthcare and the financial pressures facing the sector expected to deliver it.
Leave a Comment